James K. Luce - Concepedia

Author

James K. Luce

Anderson Hospital

Also Known As

J K Luce, J Luce, J. K. LUCE, J. K. Luce, J. Luce, JAMES K. LUCE, James K. Luce, James Luce, Jeremy Luce

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Anderson Hospital Henry Ford Hospital Wayne State University The University of Texas MD Anderson Cancer Center Ross Laboratories (United States)

About

James K. Luce is an author at Anderson Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.8K
2	Health Sciences	6	6	489
3	Natural Sciences	1	1	35
4	Biochemistry	1	1	35
5	Biomolecular Engineering	1	1	35

James K. Luce

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Phase II evaluation of adriamycin in human neoplasia Robert M. OʼBryan, James K. Luce, Robert W. Talley, Cancer	1973	415
Clinical trials with adriamycin Edward L. Middleman, James K. Luce, Emil Frei Cancer PathologyPharmacotherapyTumor BiologyTolerated DoseDrug Resistance	1971	227
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide Jeffrey A. Gottlieb, Laurence H. Baker, Joseph M. Quagliana, Cancer Medicinal ChemistryOncologyMedicineResponse RatePharmacotherapy	1972	216
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Lawrence H. Einhorn, M. A. Burgess, Carlos Vallejos, PubMed Neuro-oncologyPrognostic CorrelationsDisseminated MelanomaRadiation TherapyMedicine	1974	214
Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma James K. Luce, Jess F. Gamble, Henry E. Wilson, Cancer Lymphoid NeoplasiaMedicineMalignant Blood DisorderPathologyComplete Remission	1971	196
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy Rowan T. Chlebowski, John M. Weiner, Ralph D. Reynolds, Breast Cancer Research and Treatment Breast OncologyOncologyLong-term SurvivalBreast CancerCancer Treatment	1986	113
Phase II evaluation of bleomycin.A Southwest Oncology Group study Charles D. Haas, Charles A. Coltman, Jeffrey A. Gottlieb, Cancer	1976	111
Cell proliferation in human melanoma S Shirakawa, James K. Luce, Ian F. Tannock, Journal of Clinical Investigation Tumor BiologyComputer AnalysisMedicinePhotocarcinogenesisMelanoma	1970	101
Clinical pharmacologic observations on 6‐mercaptopurine and 6‐methylthiopurine ribonucleoside Ti Li Loo, James K. Luce, Margaret P. Sullivan, Clinical Pharmacology & Therapeutics Pharmaceutical SciencePlasma RadioactivityGastrointestinal PharmacologyGastroenterologyPharmacotherapy	1968	97
Bleomycin as a possible synchronizing agent for human tumor cells in vivo. S. C. Barranco, James K. Luce, Marvin M. Romsdahl, PubMed OncologyHuman Tumor CellsMedicinePharmacologyCancer Cell Biology	1973	89

Page 1